fingolimod hydrochloride has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berman, JN; Feng, H; Ganem, NJ; Hwang, SK; Laroche, FJF; Li, S; Liu, CT; Nguyen, G; Quinton, RJ; Shen, N; Singh, A; Thiagalingam, S; Wong, CK; Yu, W | 1 |
| Kim, ES; Kim, S; Moon, A | 1 |
| Singh, SK; Spiegel, S | 1 |
| Baxter, RC; Boyle, FM; de Silva, HC; Julovi, SM; Lin, MZ; Martin, JL | 1 |
1 review(s) available for fingolimod hydrochloride and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Sphingosine-1-phosphate signaling: A novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain.
Topics: Bortezomib; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fingolimod Hydrochloride; Humans; Lysophospholipids; Neuralgia; Signal Transduction; Sphingosine; Triple Negative Breast Neoplasms | 2020 |
3 other study(ies) available for fingolimod hydrochloride and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
S1P1 Threonine 236 Phosphorylation Mediates the Invasiveness of Triple-Negative Breast Cancer and Sensitivity to FTY720.
Topics: Animals; Fingolimod Hydrochloride; Humans; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, Lysosphingolipid; Sphingosine-1-Phosphate Receptors; Threonine; Triple Negative Breast Neoplasms; Zebrafish | 2023 |
A novel isoxazole compound CM2-II-173 inhibits the invasive phenotype of triple-negative breast cancer cells.
Topics: Apoptosis; Female; Fingolimod Hydrochloride; Humans; Isoxazoles; Male; Ovarian Neoplasms; Triple Negative Breast Neoplasms | 2023 |
Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade.
Topics: Animals; Caspase 3; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Fingolimod Hydrochloride; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Insulin-Like Growth Factor Binding Protein 3; Mice; Phosphotransferases (Alcohol Group Acceptor); Protein Kinase Inhibitors; Quinazolines; Signal Transduction; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2017 |